Skip to main content
Erschienen in: Pathology & Oncology Research 3/2013

01.07.2013 | Research

Primary Squamous Cell Carcinoma of the Endometrium Unrelated to Human Papilloma Virus: A Molecular Study

verfasst von: Giovanna Giordano, Silvia Pizzi, Cinzia Azzoni, Lorena Bottarelli, Tiziana D’Adda

Erschienen in: Pathology & Oncology Research | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

In this paper we report a molecular study of a case of Primary Endometrial Squamous Carcinoma (PESC), in which a Human Papilloma Virus (HPV) infection had been previously excluded by Polymerase Chain Reaction (PCR). The studies performed in an effort to explain the carcinogenesis included immunohistochemical over-expression of p53 and p16 proteins as previously observed in our own papers, plus microsatellite analysis of D10S1765 at 10q23.3 (PTEN) and TP53 at 17p13.1 (P53) as well as the methylation status of the of BRCA1 and p16 promoters using specific PCRs. In this rare malignancy, we found allelic imbalance (AI) at 17p13.1 (P53). Instead, AI at D10S1765 (PTEN) gene was absent. The genetic alteration of p53, with hyper-expression of p53 protein and an absence of abnormalities in the PTEN gene are consistent with the similarities between Uterine Serous Carcinoma (USC) and our case of PESC. The aberrant methylation of both p16 and BCAR1 promoters was not detected in our case. This finding too could imply that ESC is more similar to Uterine Serous Carcinoma than Uterine Endometrioid Carcinoma (UEC). Moreover, the lack of aberrant methylation of p16, which is in accordance with over-expression of p16 immunoreactivity, in the absence of HPV infection may be related to other unknown genetic alterations. In our opinion, it is hard to reach any definite conclusion concerning the carcinogenesis of PESC, because of its rarity and the very few molecular studies reported in the literature. Further studies with more numerous cases and larger molecular analyses are mandatory for this malignancy, to confirm whether it is more closely related to papillary endometrial cancer than to endometrioid carcinoma.
Literatur
1.
Zurück zum Zitat Klaes R, Friedrich T, Spitkovsky D et al (2001) Overexpression of p16ink4a as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 92:276–284PubMedCrossRef Klaes R, Friedrich T, Spitkovsky D et al (2001) Overexpression of p16ink4a as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 92:276–284PubMedCrossRef
2.
Zurück zum Zitat Kataoka A, Nishida T, Sugiyama T, Hori K, Honda S, Yakushiji M (1997) Squamous cell carcinoma of the endometrium with human papillomavirus type 31 and without tumor suppressor gene p53 mutation. Gynecol Oncol 65:180–184PubMedCrossRef Kataoka A, Nishida T, Sugiyama T, Hori K, Honda S, Yakushiji M (1997) Squamous cell carcinoma of the endometrium with human papillomavirus type 31 and without tumor suppressor gene p53 mutation. Gynecol Oncol 65:180–184PubMedCrossRef
3.
Zurück zum Zitat Pins MR, Young RH, Crum CP, Leach IH, Scully RE (1997) Cervical squamous cell carcinoma in situ with intraepithelial extension to the upper genital tract and invasion of tubes and ovaries: report of a case with human papilloma virus analysis. Int J Gynecol Pathol 16:272–278PubMedCrossRef Pins MR, Young RH, Crum CP, Leach IH, Scully RE (1997) Cervical squamous cell carcinoma in situ with intraepithelial extension to the upper genital tract and invasion of tubes and ovaries: report of a case with human papilloma virus analysis. Int J Gynecol Pathol 16:272–278PubMedCrossRef
4.
Zurück zum Zitat Wang Z, Dong J, Eyzaguirre EJ, Tang WW, Eltorky MA, Qiu S (2009) Detection of human papilloma virus subtypes 16 and P16(ink4a) in invasive squamous cell carcinoma of the fallopian tube and concomitant squamous cell carcinoma in situ of the cervix. J Obstet Gynaecol Res 35:385–389PubMedCrossRef Wang Z, Dong J, Eyzaguirre EJ, Tang WW, Eltorky MA, Qiu S (2009) Detection of human papilloma virus subtypes 16 and P16(ink4a) in invasive squamous cell carcinoma of the fallopian tube and concomitant squamous cell carcinoma in situ of the cervix. J Obstet Gynaecol Res 35:385–389PubMedCrossRef
5.
Zurück zum Zitat Bifulco G, Giampaolino P, Mandato VD, Morra I, Nappi C, Insabato L (2011) Primary squamous cell carcinoma of the endometrium: a case report. Eur J Gynaecol Oncol 32:350–352PubMed Bifulco G, Giampaolino P, Mandato VD, Morra I, Nappi C, Insabato L (2011) Primary squamous cell carcinoma of the endometrium: a case report. Eur J Gynaecol Oncol 32:350–352PubMed
6.
Zurück zum Zitat Goodrich S, Kebria-Moslemi M, Broshears J, Sutton GP, Rose P. Primary squamous cell carcinoma of the endometrium: two cases and a review of the literature. Diagn Cytopathol. 2012 Jan 12. doi:10.1002/dc.22814. [Epub ahead of print] Goodrich S, Kebria-Moslemi M, Broshears J, Sutton GP, Rose P. Primary squamous cell carcinoma of the endometrium: two cases and a review of the literature. Diagn Cytopathol. 2012 Jan 12. doi:10.​1002/​dc.​22814. [Epub ahead of print]
7.
Zurück zum Zitat Giordano G, D’Adda T, Merisio C, Gnetti L (2005) Primary squamous carcinoma of the endometrium: a case report with immunohistochemical and molecular study. Gynecol Oncol 96:876–879PubMedCrossRef Giordano G, D’Adda T, Merisio C, Gnetti L (2005) Primary squamous carcinoma of the endometrium: a case report with immunohistochemical and molecular study. Gynecol Oncol 96:876–879PubMedCrossRef
8.
Zurück zum Zitat Giordano G, Azzoni C, D’Adda T, Merisio C (2007) P16INK4a overexpression independent of Human Papilloma Virus (HPV) infection in rare subtypes of endometrial carcinomas. Pathol Res Pract 7:533–538CrossRef Giordano G, Azzoni C, D’Adda T, Merisio C (2007) P16INK4a overexpression independent of Human Papilloma Virus (HPV) infection in rare subtypes of endometrial carcinomas. Pathol Res Pract 7:533–538CrossRef
9.
Zurück zum Zitat D’Adda T, Bottarelli L, Azzoni C et al (2005) Malignancy-associated X chromosome allelic losses in foregut endocrine neoplasms: further evidence from lung tumors. Mod Pathol 18:795–805PubMedCrossRef D’Adda T, Bottarelli L, Azzoni C et al (2005) Malignancy-associated X chromosome allelic losses in foregut endocrine neoplasms: further evidence from lung tumors. Mod Pathol 18:795–805PubMedCrossRef
10.
Zurück zum Zitat Naidoo R, Chetty R (1998) The application of microsatellites in molecular pathology. Pathol Oncol Res 4:310–315PubMedCrossRef Naidoo R, Chetty R (1998) The application of microsatellites in molecular pathology. Pathol Oncol Res 4:310–315PubMedCrossRef
11.
Zurück zum Zitat Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93:9821–9826PubMedCrossRef Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93:9821–9826PubMedCrossRef
13.
Zurück zum Zitat Weissenbach J, Gyapay G, Dib C et al (1992) A second-generation linkage map of the human genome. Nature 359:794–801PubMedCrossRef Weissenbach J, Gyapay G, Dib C et al (1992) A second-generation linkage map of the human genome. Nature 359:794–801PubMedCrossRef
14.
Zurück zum Zitat Peltomaki P, Lothe RA, Aaltonen LA et al (1993) Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res 53:5853–5855PubMed Peltomaki P, Lothe RA, Aaltonen LA et al (1993) Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res 53:5853–5855PubMed
15.
Zurück zum Zitat Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M (1993) Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363:558–561PubMedCrossRef Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M (1993) Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363:558–561PubMedCrossRef
16.
Zurück zum Zitat Wirtz HC, Muller W, Noguchi T et al (1998) Prognostic value and clinicopathological profile of microsatellite instability in gastric cancer. Clin Cancer Res 4:1749–1754PubMed Wirtz HC, Muller W, Noguchi T et al (1998) Prognostic value and clinicopathological profile of microsatellite instability in gastric cancer. Clin Cancer Res 4:1749–1754PubMed
17.
Zurück zum Zitat Duggan BD, Felix JC, Muderspach LI, Tourgeman D, Zheng J, Shibata D (1994) Microsatellite instability in sporadic endometrial carcinoma. J Natl Cancer Inst 86:1216–1221PubMedCrossRef Duggan BD, Felix JC, Muderspach LI, Tourgeman D, Zheng J, Shibata D (1994) Microsatellite instability in sporadic endometrial carcinoma. J Natl Cancer Inst 86:1216–1221PubMedCrossRef
18.
Zurück zum Zitat Steele RJC, Thompson AM, Hall PA, Lane DP (1998) The p53 tumour suppressor gene. Br J Surg 85:1460–1467PubMedCrossRef Steele RJC, Thompson AM, Hall PA, Lane DP (1998) The p53 tumour suppressor gene. Br J Surg 85:1460–1467PubMedCrossRef
20.
Zurück zum Zitat Rogel A, Popliker M, Webb CG, Oren M (1985) p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors. Mol Cell Biol 5:2851–2855PubMed Rogel A, Popliker M, Webb CG, Oren M (1985) p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors. Mol Cell Biol 5:2851–2855PubMed
21.
Zurück zum Zitat Finlay CA, Hinds PW, Tan TH, Eliyahu D, Oren M, Levine AJ (1988) Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol Cell Biol 8:531–539PubMed Finlay CA, Hinds PW, Tan TH, Eliyahu D, Oren M, Levine AJ (1988) Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol Cell Biol 8:531–539PubMed
22.
Zurück zum Zitat Lakshmi S, Nair MB, Jayaprakash PG, Rajalekshmy TN, Nair MK, Pillai MR (1997) p53 protein and tumorigenesis in the uterine cervix. Gen Diagn Pathol 142:281–287PubMed Lakshmi S, Nair MB, Jayaprakash PG, Rajalekshmy TN, Nair MK, Pillai MR (1997) p53 protein and tumorigenesis in the uterine cervix. Gen Diagn Pathol 142:281–287PubMed
23.
Zurück zum Zitat Reihsaus E, Kohler M, Kraiss S et al (1990) Regulation of the level of the oncoprotein p53 in non transformed and transformed cells. Oncogene 5:137–145PubMed Reihsaus E, Kohler M, Kraiss S et al (1990) Regulation of the level of the oncoprotein p53 in non transformed and transformed cells. Oncogene 5:137–145PubMed
24.
Zurück zum Zitat Munn KE, Walker RA, Menasce L, Varley JM (1996) Mutation of the TP53 gene and allelic imbalance at chromosome 17p13 in ductal carcinoma in situ. Br J Cancer 74:1578–1585PubMedCrossRef Munn KE, Walker RA, Menasce L, Varley JM (1996) Mutation of the TP53 gene and allelic imbalance at chromosome 17p13 in ductal carcinoma in situ. Br J Cancer 74:1578–1585PubMedCrossRef
25.
Zurück zum Zitat Steck PA, Perhouse MA, Jasser SA et al (1997) Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15:356–362PubMedCrossRef Steck PA, Perhouse MA, Jasser SA et al (1997) Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15:356–362PubMedCrossRef
26.
Zurück zum Zitat Li J, Yen C, Liaw D et al (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943–1946PubMedCrossRef Li J, Yen C, Liaw D et al (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943–1946PubMedCrossRef
27.
Zurück zum Zitat Bussaglia E, del Rio E, Matias-Guiu X, Prat J (2000) PTEN mutations in endometrial carcinomas: a molecular and clinicopathologic analysis of 38 cases. Hum Pathol 31:312–317PubMedCrossRef Bussaglia E, del Rio E, Matias-Guiu X, Prat J (2000) PTEN mutations in endometrial carcinomas: a molecular and clinicopathologic analysis of 38 cases. Hum Pathol 31:312–317PubMedCrossRef
28.
Zurück zum Zitat Levine RL, Cargile CB, Blazes MS, van Rees B, Kurman RJ, Ellenson LH (1998) PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma. Cancer Res 58:3254–3258PubMed Levine RL, Cargile CB, Blazes MS, van Rees B, Kurman RJ, Ellenson LH (1998) PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma. Cancer Res 58:3254–3258PubMed
29.
Zurück zum Zitat Maxwell GL, Risinger JI, Gumbs C et al (1998) Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias. Cancer Res 58:2500–2503PubMed Maxwell GL, Risinger JI, Gumbs C et al (1998) Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias. Cancer Res 58:2500–2503PubMed
31.
Zurück zum Zitat Omura-Minamisawa M, Diccianni MB, Chang RC et al (2001) p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease. Clin Cancer Res 7:3481–3490PubMed Omura-Minamisawa M, Diccianni MB, Chang RC et al (2001) p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease. Clin Cancer Res 7:3481–3490PubMed
32.
Zurück zum Zitat Esteller M, Silva JM, Dominguez G et al (2000) Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 92:564–569PubMedCrossRef Esteller M, Silva JM, Dominguez G et al (2000) Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 92:564–569PubMedCrossRef
33.
Zurück zum Zitat Wong YF, Chung TK, Cheung TH et al (1999) Methylation of p16INK4A in primary gynecologic malignancy. Cancer Lett 136:231–235PubMedCrossRef Wong YF, Chung TK, Cheung TH et al (1999) Methylation of p16INK4A in primary gynecologic malignancy. Cancer Lett 136:231–235PubMedCrossRef
34.
Zurück zum Zitat Miki Y, Swensen J, Shattuck-Eidens D et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66–71PubMedCrossRef Miki Y, Swensen J, Shattuck-Eidens D et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66–71PubMedCrossRef
35.
Zurück zum Zitat Venkitaraman AR (2002) Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108:171–182PubMedCrossRef Venkitaraman AR (2002) Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108:171–182PubMedCrossRef
36.
37.
Zurück zum Zitat Shen S-X, Weaver Z, Xu X et al (1998) A targeted disruption of the murine BRCA1 gene causes gamma-irradiation hypersensitivity and genetic instability. Oncogene 17:3115–3124PubMedCrossRef Shen S-X, Weaver Z, Xu X et al (1998) A targeted disruption of the murine BRCA1 gene causes gamma-irradiation hypersensitivity and genetic instability. Oncogene 17:3115–3124PubMedCrossRef
38.
Zurück zum Zitat Foray N, Randrianarison V, Mrot D, Perricaudet M, Lenoir G, Feunteun J (1999) Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2. Oncogene 18:7334–7342PubMedCrossRef Foray N, Randrianarison V, Mrot D, Perricaudet M, Lenoir G, Feunteun J (1999) Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2. Oncogene 18:7334–7342PubMedCrossRef
39.
Zurück zum Zitat Xu X, Wagner KU, Larson D et al (1999) Conditional mutation of BRCA1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet 22:37–43PubMedCrossRef Xu X, Wagner KU, Larson D et al (1999) Conditional mutation of BRCA1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet 22:37–43PubMedCrossRef
40.
Zurück zum Zitat Bianco T, Chenevix-Trench G, Walsh DC, Cooper JE, Dobrovic A (2000) Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer. Carcinogenesis 21:147–151PubMedCrossRef Bianco T, Chenevix-Trench G, Walsh DC, Cooper JE, Dobrovic A (2000) Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer. Carcinogenesis 21:147–151PubMedCrossRef
41.
Zurück zum Zitat Baldwin RL, Nemeth E, Tran H et al (2000) BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study. Cancer Res 60:5329–5333PubMed Baldwin RL, Nemeth E, Tran H et al (2000) BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study. Cancer Res 60:5329–5333PubMed
42.
Zurück zum Zitat Risinger JI, Hayes AK, Berchuck A, Barrett JC (1997) PTEN/MMAC1 mutations in endometrial cancers. Cancer Res 57:4736–4738PubMed Risinger JI, Hayes AK, Berchuck A, Barrett JC (1997) PTEN/MMAC1 mutations in endometrial cancers. Cancer Res 57:4736–4738PubMed
43.
Zurück zum Zitat Seeber LM, Zweemer RP, Marchionni L et al (2010) Methylation profiles of endometrioid and serous endometrial cancers. Endocr Relat Cancer 17:663–673PubMedCrossRef Seeber LM, Zweemer RP, Marchionni L et al (2010) Methylation profiles of endometrioid and serous endometrial cancers. Endocr Relat Cancer 17:663–673PubMedCrossRef
Metadaten
Titel
Primary Squamous Cell Carcinoma of the Endometrium Unrelated to Human Papilloma Virus: A Molecular Study
verfasst von
Giovanna Giordano
Silvia Pizzi
Cinzia Azzoni
Lorena Bottarelli
Tiziana D’Adda
Publikationsdatum
01.07.2013
Verlag
Springer Netherlands
Erschienen in
Pathology & Oncology Research / Ausgabe 3/2013
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-013-9607-3

Weitere Artikel der Ausgabe 3/2013

Pathology & Oncology Research 3/2013 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.